Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ULTRAPACS

K-Number: K051813 · 2005-08-15

Decision Date2005-08-15
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

ULTRAPACS is the device name listed in this FDA 510(k) record. The listed applicant is Ultrarad Corporation. It received FDA 510(k) clearance on 2005-08-15 under 510(k) number K051813. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ULTRAPACS?

ULTRAPACS is a medical device that received FDA 510(k) clearance on 2005-08-15. The listed applicant is Ultrarad Corporation. The 510(k) number is K051813.

When did ULTRAPACS receive FDA 510(k) clearance?

ULTRAPACS received FDA 510(k) clearance on 2005-08-15, under 510(k) number K051813.

Who is the listed applicant for ULTRAPACS?

The FDA 510(k) record lists Ultrarad Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ULTRAPACS?

The FDA product code for ULTRAPACS is LLZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑